<?xml version="1.0" encoding="UTF-8"?>
<ref id="B19-cancers-10-00197">
 <label>19.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Biron</surname>
    <given-names>K.K.</given-names>
   </name>
   <name>
    <surname>Harvey</surname>
    <given-names>R.J.</given-names>
   </name>
   <name>
    <surname>Chamberlain</surname>
    <given-names>S.C.</given-names>
   </name>
   <name>
    <surname>Good</surname>
    <given-names>S.S.</given-names>
   </name>
   <name>
    <surname>Smith</surname>
    <given-names>A.A.</given-names>
    <suffix>3rd</suffix>
   </name>
   <name>
    <surname>Davis</surname>
    <given-names>M.G.</given-names>
   </name>
   <name>
    <surname>Talarico</surname>
    <given-names>C.L.</given-names>
   </name>
   <name>
    <surname>Miller</surname>
    <given-names>W.H.</given-names>
   </name>
   <name>
    <surname>Ferris</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Dornsife</surname>
    <given-names>R.E.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole 
   <sc>l</sc>-riboside with a unique mode of action
  </article-title>
  <source>Antimicrob. Agents Chemother.</source>
  <year>2002</year>
  <volume>46</volume>
  <fpage>2365</fpage>
  <lpage>2372</lpage>
  <pub-id pub-id-type="doi">10.1128/AAC.46.8.2365-2372.2002</pub-id>
  <?supplied-pmid 12121906?>
  <pub-id pub-id-type="pmid">12121906</pub-id>
 </element-citation>
</ref>
